Equillium
@EquilliumBio
Followers
201
Following
150
Media
187
Statuses
393
Resetting Balance, Restoring Health | At Equillium, we are pioneering new products to treat severe autoimmune & inflammatory diseases | $EQ
San Diego, CA
Joined February 2020
EQ504, an aryl hydrocarbon receptor (AhR) modulator is our newest asset. It targets a clinically validated pathway for the treatment of skin & GI diseases with a unique, multi-modal, non-immunosuppressive MoA that is complementary to other therapeutics.
equilliumbio.com
EQ504 targets the aryl hydrocarbon receptor, a clinically validated pathway in the treatment of both skin and gastrointestinal diseases EQ504 has a unique, multi-modal, non-immunosuppressive mechan...
0
0
0
Announced Ph3 aGVHD data. Itolizumab did not improve CR or OR rates at Day 29, but did achieve stat sig in 2nd'ry endpoints demonstrating compelling clinical benefit in longer-term outcomes, including CR at Day 99, duration of CR and failure free survival.
0
0
1
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
666
2K
9K
@EquilliumBio announces abstract at #SITC24. Poster will highlight data demonstrating that IL-15 & IL-21 augment NK and CD8 T cell activity and enhance proliferation & cytolytic function. Combo could be a promising treatment approach to stimulating anti-tumor immune response.
0
0
1
Join us on September 28 as we #WalkForAlopecia to help raise money for @NAAF_org.
naaf.org
The National Alopecia Areata Foundation’s (NAAF) 3rd Annual Walk For Alopecia is the finale of Alopecia Areata Awareness Month and it will once again bring the alopecia areata community of families,...
0
0
2
Join us on October 5th for the "2024 Walk to End Lupus Now" sponsored by the San Diego chapter of the Lupus Foundation of America. You can mkae a difference!.
0
0
1
It's conference season again! . $EQ presenting on Tuesday at @HCWCO Investor Conference to provide an update on itolizumab and Ono Pharmaceutical partnership.
0
0
3
$EQ presenting today at Wells Fargo and providing an update on itolizumab and Ono Pharmaceutical partnership.
0
0
2
Please join us in welcoming our newest Clinical Operations Team member, Annie Huynh. She joins us as a Clinical Trial Manger and will be supporting the EQUATOR program for aGVHD. In her spare time, Annie enjoys Pilates, cycling and catching halibut under the Coronado Bridge.
0
0
1
$EQ Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease. Triggers Ono Pharmaceutical's 90-Day exercise period.
0
0
0
$EQ Announces Second Quarter 2024 Estimated Cash and Investments Balance of approximately $33.3 million. An increase of approximately $1.0 million compared to the amount at the end of Q1.
equilliumbio.com
Q2 ending cash, cash equivalents and short-term investments totaled approximately $33.3 million, an increase of approximately $1.0 million compared to the amount at the end of Q1 Equillium, Inc....
0
0
1
Attend a free IDEF webinar: Dr. Brett King and his #patient discuss the complicated experience of having #AlopeciaAreata, including treatment decisions and going through pregnancy. Tuesday, July 23.@7PM ET/4PM PT.
0
0
0
RT @NAAF_org: UPCOMING #WEBINAR – Novel developments in treating #AlopeciaAreata: What is Type 2 inflammation and why is it important? . We….
0
2
0
RT @NAAF_org: You can impact #AlopeciaAreata awareness when you join the #WalkForAlopecia this September. Lace up your shoes and hit the pa….
0
2
0
EQ Announces Positive Data in Ph 2 Alopecia Areata (AA) Study.· 20% all subjects completing 24wks treatment achieved SALT ≤ 20.· 29% completed subjects with moderate - severe disease achieved SALT ≤ 20.· Drug well tolerated in subjects with no SAEs.
0
0
1
In recognition of International Celiac Disease Awareness Day, @CeliacDotOrg supports schools and students nationwide for their annual Celiac Strong Day. See how you can contribute here:.
celiac.org
Join us on May 16th for Celiac Strong Day, a nationwide initiative empowering students to raise awareness about celiac disease in their schools and communities!
0
0
0
Great event coming from @NAAF_org at the end of June, with special guests and knowledgeable speakers to offer inspiration. Medical professionals will share valuable information and advice to better understand and manage alopecia areata.
0
0
0
Equillium Announces Poster Presentation at #AAI2024, the Annual Meeting of @ImmunologyAAI . "Surface CD6 regulates T cell adhesion and migration through direct ligand interaction and stabilization of VLA4". Full poster available here:
0
0
1
Great interview with $EQ CEO, Bruce Steel, in recent Biotech & Pharmaceuticals report by @wstranscript .
0
0
2
RT @big4bio: @EquilliumBio's lupus drug improves kidney #biomarker, teeing up opt-in decision from Ono. Find out more here: .
fiercebiotech.com
Equillium’s add-on lupus treatment improved a biomarker of kidney function in an unblinded phase 1 study, setting the ball rolling toward Ono Pharmaceuticals’ court for future development work |...
0
1
0
